The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

On April 20, 2021, India’s medical societies added ivermectin to the national protocol. According to Indian and international news, an aggressive campaign by the government of the Indian state of New Delhi, where COVID was raging, showed stunning success. The Desert Review reported that in April 2021, New Delhi was experiencing a COVID epidemic crisis. The state government obliterated 97 percent of Delhi cases by distributing ivermectin.41 “IVM Crushed COVID in New Delhi,” wrote Dr. Justus R. Hope, M.D.42 Following IVM’s introduction, according to TrialSite News, cases dropped dramatically. “At the national level, the massive surge that overtook the country at the beginning of April slowed exponentially after the new COVID-19 protocol was introduced, which includes the use of ivermectin and budesonide.” 43 India showed that early combination therapy—budesonide, ivermectin, doxycycline, and zinc, costing between two and five dollars—made COVID symptoms disappear within three to five days.

By January 2021, a country of more than 1.3 billion people and a vaccine uptake of almost 7.6 percent nationally44 had witnessed only 150,000 COVID deaths.45 By comparison, the US, with a population of 331 million, had recorded 357,000 deaths.46 Many Indian officials and doctors consider ivermectin a miracle drug for controlling the outbreak.

When America’s vaccination rate was at 54 percent, cases were still rising and governments were still imposing draconian restrictions. As of August 10, 2021, the United States saw 161,990 new cases and 1,049 new deaths.51 Uttar Pradesh, in contrast, saw only 19 new cases and one death—more than 1,000 times lower than the US.

According to TrialSite News, despite the Indian government’s success in using ivermectin and budesonide, “the media hasn’t shown interest in sharing this news. Instead, the comments continue to promote remdesivir as an effective drug, and the few media outlets that do refer to ivermectin call it an ‘unproven medicine’ or an ‘outdated treatment.’ It is as if there are two different treatment realities, one on the ground and one in the local health systems. Millions of patients are now receiving ivermectin, yet one would never know by the media topics.”54 Meanwhile, the Indian state of Tamil Nadu continued using Anthony Fauci’s protocol of administering remdesivir, outlawing ivermectin, and discouraging early treatment. According to the Indian Times, Tamil Nadu continues to experience cases and fatalities that perfectly match the US catastrophe.55

On September 2, 2021 on MSNBC Tonight, Chris Hayes interviewed the president of the AMA, Dr. Gerald Harmon, who said that the AMA now advises doctors against prescribing ivermectin except in clinical trials. He explained that the AMA is taking this unprecedented step because ivermectin isn’t “approved” by the FDA for treatment of COVID-19. He failed to mention that up to 30 percent of prescriptions written by America’s doctors are for off-label uses not approved by the FDA.

The medical profession has long told doctors that their single obligation is to their patients. The AMA’s declaration helped march doctors into their new role as agents of state policy. The state policy is to prescribe treatments, not based upon the health interests of the individual patient but based upon the perceived best interests of the state.

Compare ivermectin’s safety record to Dr. Fauci’s two chosen COVID remedies, remdesivir (which hospital nurses have dubbed “Run-death-is-near”), and the COVID vaccines. Over 30 years, ivermectin has been associated with only 379 reported deaths, an impressive death/dose reporting ratio of 1/10,584,408. In contrast, over the 18 months since remdesivir received an EUA, about 1.5 million patients have received remdesivir, with 1,499 deaths reported (a dire 1/1,000 D/D ratio). Meanwhile, among recipients of COVID jabs in the US during the ten months following their rollout, some 17,000 deaths have occurred following vaccination, a reported D/D ratio of 1/13,250. Ivermectin, therefore, is thousands of times safer than remdesivir and COVID vaccines. The science also indicates that it is far more effective than either.

However, six months into the Ebola study, the trial’s Safety Review Board suddenly pulled both remdesivir and ZMapp from the trial.12 Remdesivir, it turned out, was hideously dangerous. Within 28 days, subjects taking remdesivir had lethal side effects including multiple organ failure, acute kidney failure, septic shock, and hypotension, and 54 percent of the remdesivir group died—the highest mortality rate among the four experimental drugs.13 Anthony Fauci’s drug, ZMapp, ran up the second-highest body count at 44 percent. NIAID was the primary funder of this study, and its researchers published the bad news about remdesivir in the New England Journal of Medicine in December 2019.14 By then, COVID-19 was already circulating in Wuhan. But two months later, on February 25, 2020, Dr. Fauci announced, with great fanfare, that he was enrolling hospitalized COVID patients in a clinical trial to study remdesivir’s efficacy.15 For important context, this was a month before the WHO declared the new pandemic, a time that there were only fourteen confirmed COVID cases in the United States, most from the Diamond Princess cruise ship. These individuals were among the first wave of COVID-19 hospitalizations from whom NIAID recruited the 400 US volunteers for Dr. Fauci’s remdesivir trial.16 Dr. Fauci’s press release said only that remdesivir “has shown promise in animal models for treating Middle East Respiratory Syndrome (MERS).”17 It’s unclear, then, if NIAID informed these frightened ...

Early in March 2020, the Gates Foundation bankrolled $125 million of tax-deductible grants to support drug makers to develop coronavirus treatments.30 Gates and/or his foundation had large equity stakes in many of the pharmaceutical companies that received these funds—including Gilead. On April 24, 2020, Gilead’s volunteer spokesperson Bill Gates declared: “For the novel coronavirus, the leading drug candidate in this category is remdesivir from Gilead.”

For HCQ, Dr. Fauci demanded well-designed randomized double-blind placebo-controlled trials32,33 and he warned against the use of IVM for treatment.34 In contrast, Fauci green-lighted remdesivir following studies in which the control group did not receive a real placebo.35 Instead, Fauci’s researchers used no placebo in the more severely ailing patients and gave the remaining patients an “active comparator” containing the same treatment protocol agents as used in the remdesivir arm except for substituting sulfobutyl for remdesivir as the test agent.36 Utilization of so-called “toxic” or “spiked” placebos—also known as “fauxcebos”—is a fraudulent gimmick that Dr. Fauci and his drug researchers have pioneered over forty years to conceal adverse side effects of toxic drugs for which they seek approval.

But Dr. Fauci had little reason to worry that insiders would complain about the corruption of the study, since his trusted deputy, Cliff Lane, chaired the NIH Treatment Guidelines panel.40 Lane was doubly conflicted, since he had personally overseen the remdesivir trials in China, and stood, potentially, to share in patent rewards and royalties for the drug.41 In addition to Lane, seven of the panel members had financial relationships with Gilead—and eight additional panel members had had financial relationships with Gilead prior to the past eleven months, for which they were required to declare a relationship.42 “Is it any wonder remdesivir is the only drug recommended for COVID?”

Before his study was completed or peer-reviewed, much less published, Dr. Fauci learned that The Lancet had just published a placebo-controlled Chinese study that showed remdesivir utterly ineffective at keeping hospitalized patients alive OR reducing the duration of hospitalizations.48 Even more importantly, remdesivir did not reduce the presence of the virus in the blood. Worst of all, the Chinese study confirmed remdesivir’s deadly toxicity. The Chinese regulators and researchers shuttered that trial because of potentially lethal side effects. Remdesivir caused serious injuries in 12 percent of the patients, compared to 5 percent of patients in the placebo group.49 Unlike Dr. Fauci’s trial, the Chinese study was a randomized, double-blind, placebo-controlled, multi-center, peer-reviewed study, published in the world’s premier scientific journal, The Lancet. All the underlying data was available to the incurious press and the uninformed public.

Dr. Fauci, with great fanfare, declared victory. The data from NIAID’s clinical trial for remdesivir shows “quite good news,” he said, glossing over the drug’s failure to demonstrate any mortality advantage.51 He boasted that the median time for hospitalization was eleven days for patients taking remdesivir, compared to fifteen days in the placebo group. He told the credulous press: “The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery.” He claimed that his study had therefore proven remdesivir so remarkably beneficial to COVID patients that he had decided that it would be unethical to deny Americans benefits of this wonder drug. He was, he declared, unblinding and ending the study and giving remdesivir to the placebo group. Remdesivir would be America’s new “standard of care”52 for COVID. It was, of course, all a lie.